While both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have released guidance on the use of AI in clinical trials, the technology is still le ...

Incorporating AI into various processes might make clinical trials more efficient, but it also exposes another front for hackers to attack. Regulations such as the European Union’s GDPR also ...

But AI-derived or not, a new drug candidate still has to wind its way through the painstaking clinical trial process. That is why the pharma industry is also leaning into AI as a tool to make its ...

Artificial intelligence (AI) and machine learning are here to stay, so it’s crucial to understand how they can be used to the best effect in the evolving world of clinical trials. From patient ...

Unveiling the power of AI in patient subgroups SOMS' AI-driven subgroup analysis is transforming clinical trials through real-time data processing and continuous tracking of patient subgroups.

Discover how generative AI is revolutionising clinical trials, from enhancing patient recruitment to improving data analysis. The pharmaceutical industry is on the cusp of a groundbreaking ...

The precise definition of clinical trial differs across federal regulations, policies, and other sources. Investigators should be aware that studies that meet the definition of clinical trial may be ...

Today, AI enables advancements like remote monitoring and big data analytics. This survey provides insights into attitudes and challenges in digital innovation across the clinical research industry.

Clinical trials are becoming increasingly complex, with a growing volume of data, forms, and regulations to manage ... for key insights into how AI is transforming workflows to help address ...

AI is increasingly being adopted by sponsors for various applications in clinical trials, including optimising trial design, identifying suitable patients and analysing data, among other uses.